Autopsy report · NCT00608894

LCP-Tacro vs. Azathioprine for the Treatment of Autoimmune Hepatitis

“Study was discontinued due to slow enrollment”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 month after it had already started.
• Ran for about 1 year 7 months before it stopped.
• 13 participants enrolled.
• Results were posted on the registry 10 years 8 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Veloxis Pharmaceuticals

Sponsor type

Industry

Conditions

Autoimmune Hepatitis

Interventions

LCP-Tacro (tacrolimus); Azathioprine

Participants

13

Sites

12

Countries

Canada, United States

Trials that died the same way

• Effect of Fish Oil (Omega-3 Fatty Acids) on Arteries
  “The study was discontinued early due to lack of funding and slow enrollment” (93% match in meaning)
• Dabrafenib, Trametinib, and Spartalizumab for the Treatment of BRAF V600E or V600K Mutation Positive Stage IIIB/C/D Melanoma
  “Study stopped due to slow enrollment” (91% match in meaning)
• Concurrent Nab-P/Carboplatin and Thoracic Radiotherapy in Squamous Cell Lung Cancer
  “The study was halted because enrollment was too slow” (89% match in meaning)
• Hand Injected Ventriculography vs. Power Injected Left Ventriculography
  “Study was stopped due to low enrollment.” (88% match in meaning)
• Salvage Cryotherapy in Recurrent Prostate Cancer
  “Study was ended due to low enrollment” (87% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.